RHÖN-KLINIKUM (RHK) Stock Overview
Provides in-patient, semi-patient, and outpatient healthcare services in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for RHK from our risk checks.
RHK Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €12.40 |
| 52 Week High | €16.40 |
| 52 Week Low | €11.20 |
| Beta | -0.0041 |
| 1 Month Change | -2.36% |
| 3 Month Change | -1.59% |
| 1 Year Change | -14.48% |
| 3 Year Change | -5.34% |
| 5 Year Change | -19.59% |
| Change since IPO | 379.83% |
Recent News & Updates
RHÖN-KLINIKUM's (ETR:RHK) Conservative Accounting Might Explain Soft Earnings
Apr 02
Is RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Trading At A 21% Discount?
Dec 18Recent updates
RHÖN-KLINIKUM's (ETR:RHK) Conservative Accounting Might Explain Soft Earnings
Apr 02Is RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Trading At A 21% Discount?
Dec 18RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly
Aug 16RHÖN-KLINIKUM (ETR:RHK) Is Doing The Right Things To Multiply Its Share Price
Jun 11RHÖN-KLINIKUM (ETR:RHK) Is Looking To Continue Growing Its Returns On Capital
Mar 01Some Shareholders Feeling Restless Over RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) P/E Ratio
Jan 08RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't
Jun 26RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly
Apr 25RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Mar 02Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?
Dec 19Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly
Jul 13There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital
Jun 15These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well
Sep 20Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal
Aug 11Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)
Apr 01Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?
May 14Shareholder Returns
| RHK | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.8% | 2.4% | 2.5% |
| 1Y | -14.5% | 7.2% | 8.8% |
Return vs Industry: RHK underperformed the German Healthcare industry which returned 7.8% over the past year.
Return vs Market: RHK underperformed the German Market which returned 9.6% over the past year.
Price Volatility
| RHK volatility | |
|---|---|
| RHK Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in DE Market | 13.8% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: RHK has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: RHK's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 19,041 | n/a | www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
| RHK fundamental statistics | |
|---|---|
| Market cap | €830.04m |
| Earnings (TTM) | €34.47m |
| Revenue (TTM) | €1.97b |
Is RHK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RHK income statement (TTM) | |
|---|---|
| Revenue | €1.97b |
| Cost of Revenue | €1.77b |
| Gross Profit | €199.25m |
| Other Expenses | €164.78m |
| Earnings | €34.47m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
May 07, 2026
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 10.11% |
| Net Profit Margin | 1.75% |
| Debt/Equity Ratio | 8.3% |
How did RHK perform over the long term?
See historical performance and comparisonDividends
Does RHK pay a reliable dividends?
See RHK dividend history and benchmarks| RHÖN-KLINIKUM dividend dates | |
|---|---|
| Ex Dividend Date | May 28 2026 |
| Dividend Pay Date | Jun 01 2026 |
| Days until Ex dividend | 43 days |
| Days until Dividend pay date | 47 days |
Does RHK pay a reliable dividends?
See RHK dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/13 13:58 |
| End of Day Share Price | 2026/04/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
RHÖN-KLINIKUM Aktiengesellschaft is covered by 18 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gerhard Schwarz | Baader Helvea Equity Research |
| Thomas Jones | Berenberg |
| Julien Dormois | BNP Paribas |